A Model of Triage of Serious Spinal Pathologies and Therapeutic Options Based on a Delphi Study - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Medicina Année : 2023

A Model of Triage of Serious Spinal Pathologies and Therapeutic Options Based on a Delphi Study

Résumé

Background and Objectives: The relevance of red flags in serious spinal pathology (SSP) has evolved throughout the last years. Recently, new considerations have been proposed to expand the consideration of red flags. The purpose of this study was to determine, approve and test a model for the triage and management process of SSPs based on the latest data available in the literature. Materials and Methods: The SSP model was initially built on the basis of a literature review. The model was further determined and approved by an expert panel using a Delphi process. Finally, clinical scenarios were used to test the applicability of the model.Results: After three rounds of the Delphi process, panellists reached a consensus on a final version of the model. The use of clinical scenarios by experts brought about reflexive elements both for the determined model and for the SSPs depicted in the clinical cases. Conclusions: The validation of the model and its implementation in the clinical field could help assess the skills of first-line practitioners managing spinal pain patients. To this end, the development of additional clinical scenarios fitting the determined model should be further considered.
Fichier principal
Vignette du fichier
medicina-59-01283.pdf (350.2 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04164067 , version 1 (18-07-2023)

Identifiants

Citer

Philippe Meidinger, Amélie Kéchichian, Nicolas Pinsault. A Model of Triage of Serious Spinal Pathologies and Therapeutic Options Based on a Delphi Study. Medicina, 2023, 59 (7), pp.1283. ⟨10.3390/medicina59071283⟩. ⟨hal-04164067⟩

Collections

UGA IMAG CNRS
5 Consultations
14 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More